Mirtazapine Intermediate 1 | CAS 5271-27-2 - Request Quote
Mirtazapine Intermediate 1
| SZ CAT No: | SZ-M027014 |
| CAS No | 5271-27-2 |
| Mol.F. | C11H16N2 |
| Mol.Wt. | 176.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Mirtazapine Intermediate 1 is chemically 1-methyl-3-phenylpiperazine. Mirtazapine Intermediate 1 is supplied with detailed characterization data compliant with regulatory guideline. Mirtazapine Intermediate 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirtazapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 5271-27-2
Purchase 5271-27-2
Order 5271-27-2
Enquire 5271-27-2
price of 5271-27-2
5271-27-2 Supplier
5271-27-2 Manufacturer
5271-27-2 Exporter
buy high quality Mirtazapine Intermediate 1
Purchase Mirtazapine Intermediate 1
Mirtazapine Intermediate 1 suppliers
Mirtazapine Intermediate 1 manufacturers
Mirtazapine Intermediate 1 price
Order Mirtazapine Intermediate 1
Enquire Mirtazapine Intermediate 1
Mirtazapine Intermediate 1 cost
Mirtazapine Intermediate 1 Supplier
Mirtazapine Intermediate 1 Distributor
Mirtazapine Intermediate 1 for Method Validation
Mirtazapine Reference Standard
Mirtazapine Intermediate 1 for ANDA Filing
Mirtazapine Intermediate 1 for Forced Degradation Studies
Mirtazapine Intermediate 1 Identification Standards
Mirtazapine Intermediate 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


